Effect of in-utero polysubstance exposure on adolescent cardiovascular disease risk: Results from the Maternal Lifestyle Study
Weerakoon S, Chen B, Harrell M, Vidot D, Messiah S. Effect of in-utero polysubstance exposure on adolescent cardiovascular disease risk: Results from the Maternal Lifestyle Study. Progress In Pediatric Cardiology 2022, 66: 101528. DOI: 10.1016/j.ppedcard.2022.101528.Peer-Reviewed Original ResearchCardiovascular disease riskMaternal substance useMaternal Lifestyle StudySystolic blood pressureDisease riskLifestyle StudySubstance useBlood pressureRates of polysubstance usePolysubstance useCardiovascular disease preventionExposed to tobaccoCombination of tobaccoPregnancy rangeNational Institute on Drug AbuseNormal birthweightPolysubstance exposureDisease preventionPregnancyCardiovascular diseaseHighest prevalenceTobaccoDrug abusePregnancy statusIllicit substancesLongitudinal effect of prenatal polydrug use and birthweight status on pediatric growth
Weerakoon S, Chen B, Harrell M, Vidot D, Messiah S. Longitudinal effect of prenatal polydrug use and birthweight status on pediatric growth. Children's Health Care 2022, 52: 244-263. DOI: 10.1080/02739615.2022.2078826.Peer-Reviewed Original ResearchMaternal Lifestyle StudyLow birthweightBMI percentilePediatric growthBorn low birthweightCombination of drug useDrug useMaternal drug useChildren exposed to drugsNational Institute on Drug AbuseBirthweight statusBirthweightPolydrug useAnthropometric growthDrug abuseLifestyle StudyPercentileBMIUteroUseLongitudinal effectsYearsDrug